TPTZ shows bioactivity in various assays, indicating a range of potential effects on different biological pathways. It exhibits potent inhibitory activity on targets such as Human Jumonji Domain Containing 2E, Tyrosyl-DNA Phosphodiesterase, Fructose-1,6-bisphosphate Aldolase, ELG1-dependent DNA repair, malarial parasite plastid function, Polymerase Iota, TGF-b, GLP-1 Receptor, ATXN expression, tyrosyl-DNA phosphodiesterase 1, and induction of synthetic lethality in tumor cells. Additionally, this compound demonstrates antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus MRSA, Acinetobacter baumannii, and Klebsiella pneumoniae, with varying degrees of inhibition ranging from -0.02% to 11.58%, as well as antifungal activity against Candida albicans. These activities suggest that TPTZ could be a promising candidate for further investigation in drug development research, particularly for its potential effects related to DNA repair, cell growth, enzyme inhibition, cytotoxicity, antibacterial, antifungal, and antimalarial properties..
Note: Summary generated by AI. Data source: ChEMBL 